CAPR
Capricor Therapeutics Inc
8.60$
-1.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +58.1% | -15.8% | -22.6% | +142.8% | +83.4% | -9.8% | -13.1% | -5.3% | +181.5% | -8.3% | +13.0% | |
| – | +72.2% | -18.6% | -25.9% | +179.8% | +90.4% | -10.5% | -15.1% | -18.7% | +219.9% | -12.3% | -14.5% | |
| – | +63.6% | -57.7% | +72.0% | +539.7% | -83.5% | +155.1% | -19.3% | -16.1% | +1,375.4% | -63.4% | -80.1% | |
| – | +38.4% | +1.1% | -26.2% | +188.6% | +78.2% | -4.4% | -15.2% | -19.7% | +222.8% | -12.4% | -14.6% | |
| – | +1,794.2% | -96.4% | +0.3% | +10.7% | +2,430.9% | -99.4% | -0.5% | -0.6% | +0.0% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -7.2% | -14.2% | -13.7% | -7.8% | +1.3% | +4.4% | +9.5% | +48.9% | +17.8% | -5.1% | +157.5% | |
| – | -5.0% | -15.6% | -15.3% | -8.4% | +2.7% | +6.2% | +27.1% | -0.9% | +27.3% | -6.1% | -2.0% | |
| – | +2.7% | +3.0% | +2.7% | +2.6% | +2.6% | +0.9% | +401.8% | -17.3% | +3.7% | +98.1% | -79.3% | |
| – | -8.1% | 0.0% | -1.3% | +5.9% | -49.6% | +60.0% | -8.4% | -43.5% | -39.2% | +137.4% | -21.6% | |
| – | – | -18.4% | -37.6% | +493.5% | +113.1% | -12.2% | -17.8% | -20.1% | +264.6% | -8.9% | -11.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.7% | +17.1% | +1.6% | +3.9% | +6.4% | +29.6% | +0.2% | +0.0% | +6.9% | +17.6% | +0.9% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.